• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D、甲状旁腺激素、钙与前列腺癌风险:一项前瞻性巢式病例对照研究。

Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study.

机构信息

Department of Urology, Skåne University Hospital Malmö, Lund University, Malmö, Sweden.

出版信息

Cancer Causes Control. 2012 Aug;23(8):1377-85. doi: 10.1007/s10552-012-9948-3. Epub 2012 Jun 16.

DOI:10.1007/s10552-012-9948-3
PMID:22706676
Abstract

OBJECTIVE

To examine the risk of prostate cancer in relation to pre-diagnostic serum levels of vitamin D (25OHD(2) and 25OHD(3)), PTH, and calcium.

METHODS

Nine hundred forty-three incident prostate cancer cases were identified in the Malmö Diet and Cancer Study cohort, and each was matched with one control using incidence density matching with age as the underlying timescale. We also matched for calendar time and age at inclusion. Logistic regression analysis yielded odds ratios with 95 % confidence intervals for different quartiles and deciles. All analyses were repeated stratified for age and body mass index (BMI).

RESULTS

We found a weak trend toward increasing prostate cancer risk with rising vitamin D levels (p-trend across quartiles, 0.048). Dividing the cohort into deciles showed a nonlinear association. Compared to decile one, the prostate cancer risk was highest in deciles seven and eight, which corresponded to vitamin D levels of 91-97 nmol/L (1.68; 1.06-2.68), and 98-106 nmol/L (1.80; 1.13-2.85). In the other deciles, there was no association between prostate cancer risk and vitamin D levels. Albumin-adjusted calcium was positively associated with an increased risk for prostate cancer among men aged 55-65 with a BMI <25 (2.07; 1.08-3.97). No association was observed between pre-diagnostic PTH and subsequent prostate cancer incidence, and the stratified analyses revealed no other convincing relationships.

CONCLUSIONS

This study suggests a possible weak positive nonlinear association between vitamin D and the risk of prostate cancer.

摘要

目的

研究与前列腺癌发病相关的维生素 D(25OHD(2) 和 25OHD(3))、甲状旁腺激素(PTH)和钙的预诊断血清水平。

方法

在马尔默饮食与癌症研究队列中,确定了 943 例前列腺癌新发病例,并使用基于年龄的密度匹配方法,按年龄作为潜在时间尺度,为每个病例匹配一名对照。我们还按日历时间和纳入时的年龄进行了匹配。使用 logistic 回归分析得出了不同四分位和十分位数的比值比及其 95%置信区间。所有分析均按年龄和体重指数(BMI)进行分层重复。

结果

我们发现随着维生素 D 水平的升高,前列腺癌的发病风险呈上升趋势(四分位组间趋势,p=0.048)。将队列分为十分位数显示出非线性关联。与十分位一相比,十分位七和十分位八的前列腺癌风险最高,对应的维生素 D 水平分别为 91-97 nmol/L(1.68;1.06-2.68)和 98-106 nmol/L(1.80;1.13-2.85)。在其他十分位中,维生素 D 水平与前列腺癌风险之间没有关联。对于 BMI<25 的 55-65 岁男性,白蛋白校正后的钙与前列腺癌风险呈正相关(2.07;1.08-3.97)。预诊断的甲状旁腺激素与随后的前列腺癌发病之间没有关联,分层分析也没有发现其他有说服力的关系。

结论

本研究表明,维生素 D 与前列腺癌风险之间可能存在微弱的正非线性关联。

相似文献

1
Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study.维生素 D、甲状旁腺激素、钙与前列腺癌风险:一项前瞻性巢式病例对照研究。
Cancer Causes Control. 2012 Aug;23(8):1377-85. doi: 10.1007/s10552-012-9948-3. Epub 2012 Jun 16.
2
Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study.血清维生素 D、甲状旁腺激素和钙水平与乳腺癌风险的前瞻性巢式病例对照研究。
Int J Cancer. 2010 Nov 1;127(9):2159-68. doi: 10.1002/ijc.25215.
3
Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case-control study.维生素D、甲状旁腺激素、钙与前列腺癌肿瘤侵袭性:一项前瞻性巢式病例对照研究
Cancer Causes Control. 2016 Jan;27(1):69-80. doi: 10.1007/s10552-015-0684-3. Epub 2015 Oct 30.
4
Vitamin D, PTH, and calcium in relation to survival following prostate cancer.维生素D、甲状旁腺激素和钙与前列腺癌患者生存率的关系
Cancer Causes Control. 2016 May;27(5):669-77. doi: 10.1007/s10552-016-0740-7. Epub 2016 Mar 29.
5
Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.代谢综合征相关因素与维生素D对前列腺癌风险的相互作用。
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302-7. doi: 10.1158/1055-9965.EPI-06-0777.
6
Serum calcium and the risk of prostate cancer.血清钙与前列腺癌风险
Cancer Causes Control. 2009 Sep;20(7):1205-14. doi: 10.1007/s10552-009-9342-y. Epub 2009 Apr 18.
7
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中的维生素D状态、季节变化、甲状旁腺腺瘤重量和骨密度
Clin Endocrinol (Oxf). 2005 Nov;63(5):506-13. doi: 10.1111/j.1365-2265.2005.02371.x.
8
Factors associated with elevated or blunted PTH response in vitamin D insufficient adults.维生素D不足成年人中与甲状旁腺激素反应升高或减弱相关的因素。
J Intern Med. 2009 Apr;265(4):488-95. doi: 10.1111/j.1365-2796.2008.02044.x. Epub 2008 Nov 15.
9
Dietary intake of calcium, vitamin D, phosphorus and the risk of prostate cancer.钙、维生素D、磷的膳食摄入量与前列腺癌风险
Eur Urol. 2005 Jul;48(1):27-33. doi: 10.1016/j.eururo.2005.03.023. Epub 2005 Apr 8.
10
Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.循环维生素D代谢产物与前列腺癌后续发展的关系
Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):121-6.

引用本文的文献

1
Vitamins in the Pathogenesis of Prostate Cancer: Implications for Prevention and Therapeutic Support.维生素在前列腺癌发病机制中的作用:对预防和治疗支持的意义
Int J Mol Sci. 2025 May 2;26(9):4336. doi: 10.3390/ijms26094336.
2
The double disparity: Vitamin D deficiency and lethal prostate cancer in black men.双重差异:黑人男性中的维生素D缺乏与致命性前列腺癌
J Steroid Biochem Mol Biol. 2025 Mar;247:106675. doi: 10.1016/j.jsbmb.2025.106675. Epub 2025 Jan 17.
3
How competing risks affect the epidemiological relationship between vitamin D and prostate cancer incidence? A population-based study.
竞争风险如何影响维生素 D 与前列腺癌发病率之间的流行病学关系?一项基于人群的研究。
Andrologia. 2022 Jul;54(6):e14410. doi: 10.1111/and.14410. Epub 2022 Feb 28.
4
Parathyroid hormone is associated with prostate cancer.甲状旁腺激素与前列腺癌有关。
Prostate Int. 2020 Sep;8(3):116-120. doi: 10.1016/j.prnil.2020.02.002. Epub 2020 Feb 26.
5
Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank.研究英国生物库中与前列腺癌发病率和死亡率相关的潜在新型生化因素。
Br J Cancer. 2020 Dec;123(12):1808-1817. doi: 10.1038/s41416-020-01081-3. Epub 2020 Sep 23.
6
Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer.雄激素剥夺治疗后,血浆 25-羟维生素 D 和 1,25-二羟维生素 D 水平与侵袭性前列腺癌患者的死亡率。
Sci Rep. 2020 May 8;10(1):7736. doi: 10.1038/s41598-020-62182-w.
7
Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D.维生素 D 调控异基因造血干细胞移植中的免疫平衡
Front Immunol. 2019 Nov 5;10:2586. doi: 10.3389/fimmu.2019.02586. eCollection 2019.
8
Mendelian randomization does not support serum calcium in prostate cancer risk.孟德尔随机化不支持血清钙与前列腺癌风险之间的关联。
Cancer Causes Control. 2018 Nov;29(11):1073-1080. doi: 10.1007/s10552-018-1081-5. Epub 2018 Oct 10.
9
Vitamin D in Graves Disease: Levels, Correlation with Laboratory and Clinical Parameters, and Genetics.格雷夫斯病中的维生素D:水平、与实验室及临床参数的相关性以及遗传学
Eur Thyroid J. 2018 Jan;7(1):27-33. doi: 10.1159/000484521. Epub 2017 Nov 21.
10
Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies.循环维生素D浓度与前列腺癌风险:前瞻性研究的剂量反应荟萃分析
Ther Clin Risk Manag. 2018 Jan 9;14:95-104. doi: 10.2147/TCRM.S149325. eCollection 2018.